The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
Open accessAbstract
Activation of hepatic stellate cells (HSCs) and their trans-differentiation towards collagen-secreting myofibroblasts (MFB) promote liver fibrosis progression. During chronic liver disease, resting HSCs become activated by inflammatory and injury signals. However, HSCs/MFB not only produce collagen, but also secrete cytokines, participate in metabolism, and have biomechanical properties. We herein aimed to characterize the heterogeneity of these liver mesenchymal cells by single cell RNA sequencing. In vivo resting HSCs or activated MFB were isolated from C57BL6/J mice challenged by carbon tetrachloride (CCl4) intraperitoneally for 3 weeks to induce liver fibrosis and compared to in vitro cultivated MFB. While resting HSCs formed a homogenous population characterized by high platelet derived growth factor receptor β (PDGFRβ) expression, in vivo and in vitro activated MFB split into heterogeneous populations, characterized by α-smooth muscle actin (α-SMA), collagens, or immunological markers. S100 calcium binding protein A6 (S100A6) was a universal marker of activated MFB on both the gene and protein expression level. Compared to the heterogeneity of in vivo MFB, MFB in vitro sequentially and only transiently expressed marker genes, such as chemokines, during culture activation. Taken together, our data demonstrate the heterogeneity of HSCs and MFB, indicating the existence of functionally relevant subsets in hepatic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ScRNA-seq allows for high-resolution transcriptomic profiling of mesenchymal subpopulations during liver fibrosis, revealing that chemokine/cytokine release and extracellular matrix production are diversified among HSC/myofibroblast subpopulations owing to a higher degree of cellular heterogeneity than previously appreciated.109–111”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [110]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Fcna (a marker of quiescent hepatic stellate cells 53 )”
From Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis (2024) · cites this paper as [53]
In the citing paper
“scRNAseq data from mouse fibrosis models revealed that chemokine/cytokine release and ECM production appears to be diversified between HSC/myofibroblast subpopulations.130”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [130]
In the citing paper
“Unbiased cross-species mapping of scRNAseq data using canonical correlation analysis (CCA)21 confirmed that murine and human scar-associated macrophages represent corollary populations.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“Upregulated expression of chemokines, such as CCL2, CXCL1, or CXCL12, and collagens, particularly COL1A2, COL3A1, or COL5A2, are often named attributes for activated MFB [13].”
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965 · cited 1×
“Liver fibrosis is also considered as a cornerstone event in the progression toward liver cirrhosis or hepatocellular carcinoma [15].”
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
MacParland, S. A., Liu, J. C., Ma, X.-Z., Innes, B. T., Bartczak, A. M., Gage, B. K., Manuel, J., Khuu, N., Echeverri, J., Linares, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06318-7 · Cited by 1,552
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485 · cited 1×
“Preventing or reversing excessive hepatic scarring is a major therapeutic target in treating chronic liver diseases, such as viral hepatitis and alcoholic and non-alcoholic steatohepatitis [2].”
Pathobiology of liver fibrosis: a translational success story
Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015) · Gut · doi:10.1136/gutjnl-2014-306842 · Cited by 894 · cited 1×
“The upregulation of collagens and α-SMA in MFB is a well-established finding [16] and was confirmed by our single-cell based data for MFB in vivo as well as in vitro.”
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.003 · Cited by 538 · cited 1×
“At present, α-SMA is largely accepted as a marker of activated MFB [12].”
Self-citationInflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis
Meng, X.-M., Wang, S., Huang, X.-R., Yang, C., Xiao, J., Zhang, Y., To, K.-F., Nikolic-Paterson, D. J., & Lan, H.-Y. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.402 · Cited by 325 · cited 2×
“Due to the combination of characteristics of myeloid leukocytes, as well as of myofibroblasts, cluster MFB II most likely includes trans-differentiated myeloid myofibroblasts, which have been described before [11].”
Weiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256 · cited 3×
“, contraction and vascular resistance regulation in the liver), and lipid metabolism to immune regulation [4], raising the question about yet unrecognized, functionally diverse subsets of HSCs/MFB.”
Self-citationKrenkel, O., Hundertmark, J., Abdallah, A. T., Kohlhepp, M., Puengel, T., Roth, T., Branco, D. P. P., Mossanen, J. C., Luedde, T., Trautwein, C., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318382 · Cited by 220 · cited 1×
“After, library generation sequencing was performed by Illumina sequencing on a NextSeq 550 (IZKF genomics facility of the RWTH Aachen University, Aachen, Germany) as detailed before [6].”
Self-citationUpdate on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques
Tacke, F., & Weiskirchen, R. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.92 · Cited by 205 · cited 1×
“Ultrapure FACS-sorted mouse HSCs were therefore cultivated for up to 9 days on uncoated plastic dishes, the standard model of HSCs to MFB trans-differentiation in vitro [14].”
Self-citationInflammasomes in liver fibrosis
Alegre, F., Pelegrin, P., & Feldstein, A. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1601350 · Cited by 176 · cited 1×
“Hepatic stellate cell (HSC) activation and their trans-differentiation to myofibroblasts (MFB) due to chronic hepatic inflammation is a major hallmark feature of liver fibrosis [1].”
Liver Fibrosis: From Pathogenesis to Novel Therapies
Weiskirchen, R., & Tacke, F. (2016) · Digestive Diseases · doi:10.1159/000444556 · Cited by 167 · cited 2×
“, neutrophils via CXCL1 and monocytes via CCL2, which has been linked to exacerbated hepatic inflammation [3].”
Self-citationThe characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis
Karin, D., Koyama, Y., Brenner, D. A., & Kisseleva, T. (2016) · Differentiation · doi:10.1016/j.diff.2016.07.001 · Cited by 141 · cited 1×
“The cluster MFB IV showed some features that had been previously reported for portal fibroblasts [19].”
Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
Koyama, Y., Wang, P., Liang, S., Iwaisako, K., Liu, X., Xu, J., Zhang, M., Sun, M., Cong, M., Karin, D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88845 · Cited by 124 · cited 1×
“Some of these marker genes have been described for portal fibroblasts [10].”
ANGPTL6 expression is coupled with mitochondrial OXPHOS function to regulate adipose FGF21
Kang, S., Yi, H., Choi, M. J., Ryu, M. J., Jung, S.-B., Chung, H. K., Chang, J. Y., Kim, Y. K., Lee, S. E., Kim, H. W., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0549 · Cited by 37 · cited 1×
“Besides common markers, such as PDGFR-β or various collagens, resting HSCs were uniquely characterized by a high expression of ficolin A (Fcna), which has been described to trim extracellular collagen as well as being an activator of a lectin complement pathway, and the hepatokine (Angptl6), an inducer of energy expen…”
Isolation and Time Lapse Microscopy of Highly Pure Hepatic Stellate Cells
Bartneck, M., Warzecha, K. T., Tag, C. G., Sauer-Lehnen, S., Heymann, F., Trautwein, C., Weiskirchen, R., & Tacke, F. (2015) · Analytical Cellular Pathology · doi:10.1155/2015/417023 · Cited by 34 · cited 1×
“Ultrapure HSCs were isolated from the liver of healthy C57Bl6/J mice by collagenase digestion and differential gradient centrifugation, followed by fluorescence activated cell sorting (FACS) purification for UV autofluorescence as described before [5].”
Self-citationXia, P., He, H., Kristine, M. S., Guan, W., Gao, J., Wang, Z., Hu, J., Han, L., Li, J., Han, W., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.030 · Cited by 30 · cited 1×
“Data from mouse models of fibrosis indicated that recombinant S100A6 would aggravate fibrogenesis via inducing HSCs proliferation [18].”
Leptin regulates the expression of angiopoietin-like 6
Kim, M.-J., Namkung, J., Chang, J. S., Kim, S., Park, K., & Kong, I. D. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.180 · Cited by 15 · cited 1×
“Besides common markers, such as PDGFR-β or various collagens, resting HSCs were uniquely characterized by a high expression of ficolin A (Fcna), which has been described to trim extracellular collagen as well as being an activator of a lectin complement pathway, and the hepatokine (Angptl6), an inducer of energy expen…”
Cited by
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Hepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
“Interestingly, even fibrotic livers contain a population of HSCs with a resting (or probably weakly activated) phenotype that express various growth factors and cytokines and suppress liver inflammation and fibrosis 158,159 .”
Self-citationWound healing, fibroblast heterogeneity, and fibrosis
Talbott, H. E., Mascharak, S., Griffin, M., Wan, D. C., & Longaker, M. T. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.07.006 · Cited by 795
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Cancer-associated fibroblasts in the single-cell era
Lavie, D., Ben-Shmuel, A., Erez, N., & Scherz-Shouval, R. (2022) · Nature Cancer · doi:10.1038/s43018-022-00411-z · Cited by 616
Metadata
- Authors
- Krenkel, O., Hundertmark, J., Ritz, T., Weiskirchen, R., & Tacke, F.
- Affiliations
- Boehringer Ingelheim (Germany) (DE)
- Universitätsklinikum Aachen (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Tacke, Frank
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-05-24
- Volume
- 8
- Issue
- 5
- Pages
- 503
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6562512
- OpenAlex
- W2945705065
- Cited by
- 241
- References
- 20
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 23 · 2023: 40 · 2022: 38 · 2021: 37 · 2020: 33 · 2019: 10
- FWCI
- 18.80
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (SFB/TRR57, Ta434/3-1, Ta434/5-1)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- hepatic stellate cells, myofibroblasts, liver fibrosis, cellular heterogeneity, hepatic stellate cell activation, transdifferentiation, S100A6, PDGFRβ, alpha-smooth muscle actin, collagen, carbon tetrachloride, chemokines, single-cell RNA sequencing
- MeSH terms
- S100 Calcium Binding Protein A6, Actins, Animals, Base Sequence, Carbon Tetrachloride, Cells, Cultured, Collagen, Disease Models, Animal, Liver, Liver Cirrhosis, Mice, Inbred C57BL, Gene Expression, Sequence Analysis, RNA, Genetic Heterogeneity, Cell Cycle Proteins, Chemokines, Receptor, Platelet-Derived Growth Factor beta, Mice, Hepatic Stellate Cells, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.